Skip to main content

Table 6 Multivariate Cox regression analysis of overall survival in the study population

From: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

Characteristic

HR (95% CI)

p

ICI type

 Anti-PD-1/PD-L1

Reference

 

 Anti-CTLA-4

0.85 (0.56–1.28)

0.434

 Combination

0.78 (0.58–1.05)

0.097

Stage IV cancer

1.63 (1.03–2.60)

0.038

IMDC

0.45 (0.34–0.61)

< 0.001

Anaerobic antibiotic therapy

1.44 (1.11–1.87)

0.007

  1. Abbreviations: HR Hazard ratio, CI Confidence interval
Back to article page